References
- GibofskyAOverview of epidemiology, pathophysiology, and diagnosis of rheumatoid arthritisAm J Manag Care20121813 SupplS295S30223327517
- OllendorfDAChapmanRPearsonSDTargeted immune modulators for rheumatoid arthritis: effectiveness & valueInstitute for Clinical and Economic Review2017 https://icer-review.org/wp-content/uploads/2016/08/NECEPAC_RA_Draft_Report_012017.pdfAccessed November 30, 2018
- GibofskyAEpidemiology, pathophysiology, and diagnosis of rheumatoid arthritis: a synopsisAm J Manag Care2014207 SupplS128S13525180621
- BirnbaumHPikeCKaufmanRMarynchenkoMKidoleziYCifaldiMSocietal cost of rheumatoid arthritis patients in the USCurr Med Res Opin2010261779019908947
- SinghJASaagKGBridgesSL2015 American College of Rheu-matology guideline for the treatment of rheumatoid arthritisArthritis Rheumatol2016681126
- SmolenJSBreedveldFCBurmesterGRTreating rheumatoid arthritis to target: 2014 update of the recommendations of an international task forceAnn Rheum Dis201675131525969430
- SmolenJSLandewéRBijlsmaJEULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2016 updateAnn Rheum Dis201776696097728264816
- OwensGMOptimizing rheumatoid arthritis therapy: using objective measures of disease activity to guide treatmentAm Health Drug Benefits20158735436026557229
- SinghJASaagKGBridgesSL2015 American college of rheu-matology guideline for the treatment of rheumatoid arthritisArthritis Rheumatol2016681126
- SIMPONI ARIA® (golimumab) injectionPrescribing InformationHorsham, PA 19044 USAJanssen Biotech, Inc. Revised May 2018. Available from: http://www.janssenlabels.com/package-insert/product-monograph/prescribing-information/SIMPONI+ARIA-pi.pdfAccessed June 20, 2018
- WeinblattMEBinghamCOMendelsohnAMIntravenous goli-mumab is effective in patients with active rheumatoid arthritis despite methotrexate therapy with responses as early as week 2: results of the phase 3, randomised, multicentre, double-blind, placebo-controlled GO-FURTHER trialAnn Rheum Dis201372338138922661646
- REMICADE® (infliximab)Prescribing InformationHorsham, PA 19044 USAJanssen Biotech, Inc. Revised June 2018. Available from: http://www.janssenlabels.com/package-insert/product-monograph/prescribing-information/REMICADE-pi.pdfAccessed June 20, 2018
- BradyBLTkaczJPLoflandJMeyerRBolgeSCPrescribing patterns of intravenous golimumab for rheumatoid ArthritisClin Ther20153792028203626210073
- EllisLReedGShanYPatient characteristics and real-world utilization of intravenous golimumab in a population of rheumatoid arthritis patients observed in the corrona Registry. Academy of Managed Care Pharmacy Nexus 2016. National Harbor, Maryland. October 3–6, 2016JMCP201622S83 Available from: https://www.jmcp.org/pb-assets/Poster%20Abstract%20Supplements/Oct2016Abstracts.pdfAccessed July 11, 2018
- TingGSchneeweissSScrantonRDevelopment of a health care utilisation data-based index for rheumatoid arthritis severity: a preliminary studyArthritis Res Ther2008104R9518717997
- DeyoRACherkinDCCiolMAAdapting a clinical comorbidity index for use with ICD-9-CM administrative databasesJ Clin Epidemiol19924566136191607900
- FarleyJFHarleyCRDevineJWA comparison of comorbidity measurements to predict healthcare expendituresAm J Manag Care200612211011716464140
- United States Department of Labor, Bureau of Labor StatisticsConsumer Price Index (CPI) Available from: https://www.bls.gov/cpi/Accessed July 12, 2017
- Institute of Medicine (US) Committee on Quality of Healthcare in AmericaCrossing the Quality Chasm: A New Health System for the 21st CenturyWashington, DCNational Academies Press2001
- The six domains of health care quality (Content last reviewed March 2016)Rockville, MDAgency for Healthcare Research and Quality Available from: http://www.ahrq.gov/professionals/quality-patient-safety/talkingquality/create/sixdomains.htmlAccessed July 11, 2018
- AWARE clinical trialU.S. National Library of Medicine2018 https://clinicaltrials.gov/ct2/show/NCT02728934
- DanielSRMcdermottJDLeCPierceCAZiskindMAEllisLAA real-world, multi-site, observational study of infusion time and treatment satisfaction with rheumatoid arthritis patients treated with intravenous golimumab or infliximabJ Med Econ201821772473129718743